Product Information
SODIUM BICARBONATE 8.4% VIAL is a generic product labeled by Hospira Inc., priced at $0.1540 per ML under NDC 00409662514. Its NADAC has been published 197 times since May 26, 2021.
Strength
84 mg/mL
Manufacturer
Hospira Inc.NDC
00409662514
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
SODIUM BICARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA202432On Market Since
3/1/2021
Pharmacological Classes
Price Statistics
The NADAC for SODIUM BICARBONATE 8.4% VIAL has been published 197 times since May 26, 2021, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1540 per ML |
|---|---|
| All-time high | $0.2082 (Apr 16, 2025) |
| All-time low | $0.1540 (Apr 22, 2026) |
| 52-week high | $0.1758 |
| 52-week low | $0.1540 |
| Median price | $0.1721 |
| Average price | $0.1727 |
| Largest weekly change | +11.4% (Feb 19, 2025) |
| Weeks tracked | 197 |
| Tracking since | May 26, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SODIUM BICARBONATE 8.4% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SODIUM BICARBONATE 8.4% VIAL, manufactured by Hospira Inc., is $0.1540 per ML (NDC 00409662514), effective Jun 24, 2026.
How has the price of SODIUM BICARBONATE 8.4% VIAL changed over time?
Over the history we have for it, the NADAC for SODIUM BICARBONATE 8.4% VIAL has declined 13.1%. It has been tracked across 197 weekly CMS publications since May 26, 2021.
What are the highest and lowest recorded NADAC prices for SODIUM BICARBONATE 8.4% VIAL?
Since May 26, 2021, the NADAC for SODIUM BICARBONATE 8.4% VIAL has ranged from a low of $0.1540 (Apr 22, 2026) to a high of $0.2082 (Apr 16, 2025), with a median of $0.1721 per ML.
Are there cheaper alternatives to SODIUM BICARBONATE 8.4% VIAL?
7 NADAC-published products share the same active ingredient, strength, and dosage form as SODIUM BICARBONATE 8.4% VIAL, but none are currently priced below it.
Who manufactures SODIUM BICARBONATE 8.4% VIAL?
SODIUM BICARBONATE 8.4% VIAL (NDC 00409662514) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification